Scarica l'app Stockscreener
4.33
6.28%
-0.29
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché HSDT Giù?
Forum
Previsione
Frazionamento azionario
Helius Medical Technologies Inc Borsa (HSDT) Ultime notizie
Newtown-Based Helius Medical Technologies Issues Reverse Stock Split - BUCKSCO.Today
Helius Medical Technologies announces 1-for-15 reverse stock split - MSN
HELIUS MEDICAL TECHNOLOGIES, INC. SEC 10-Q Report - TradingView
Helius Medical Technologies initiates 1-for-15 reverse stock split to meet Nasdaq requirements - The Business Journals
Helius Medical (HSDT) Initiates 1-for-15 Reverse Stock Split | H - GuruFocus
Helius Announces 1-for-15 Reverse Stock Split To Regain Nasdaq Compliance - Nasdaq
HSDT stock touches 52-week low at $0.26 amid sharp annual decline - Investing.com
Helius Medical Technologies Announces Reverse Stock Split - marketscreener.com
Helius Medical announces 1-for-15 reverse stock split By Investing.com - Investing.com India
Helius Medical announces 1-for-15 reverse stock split - Investing.com
Helius Medical's 1:15 Reverse Split Aims to Meet Nasdaq Requirements: What Shareholders Must Know - Stock Titan
Helius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 Million Gross Proceeds Priced At-the-Market - The Globe and Mail
Helius Medical secures $1.3M in private placement - Investing.com Australia
Helius Medical secures $1.3M in private placement By Investing.com - Investing.com South Africa
HELIUS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Helius Medical Technologies, Inc. To Contact The Firm - ACCESS Newswire
Helius Medical Technologies Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing - Quantisnow
HSDT stock plunges to 52-week low of $0.37 amid steep decline - Investing.com
Virtu Financial LLC Purchases New Shares in Helius Medical Technologies, Inc. (NASDAQ:HSDT) - Defense World
Helius Medical Unveils Revelation Neuro to Pioneer AI-Powered Neurorehabilitation - MSN
Helius Medical Creates Brain-Computer Interface Subsidiary - Medical Product Outsourcing
SEC Form 424B5 filed by Helius Medical Technologies Inc. - Quantisnow
Helius Medical Technologies Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Helius Medical Technologies Inc. (HSDT) reports earnings - Quartz
Chronic Traumatic Encephalopathy Pipeline 2025: MOA, ROA, - openPR.com
Helius Medical Technologies Inc expected to post a loss of 94 cents a shareEarnings Preview - TradingView
Chronic Traumatic Encephalopathy Treatment Market Size in 7MM - openPR.com
Helius Medical Technologies Reports Positive Preliminary Results from PoNSTEP Study - MSN
Helius Medical Technologies (HSDT) Expected to Announce Quarterly Earnings on Wednesday - The AM Reporter
Helius Medical Secures First Insurance Reimbursement for PoNS Device - MSN
Helius joins BCI landscape with new subsidiary - Yahoo
Helius Medical launches AI-driven BCI subsidiary - Investing.com Australia
Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface ('BCI”) Technology Private Subsidiary - The Manila Times
Helius Medical launches AI-driven BCI subsidiary By Investing.com - Investing.com UK
Helius Medical Technologies, Inc. Announces the - GlobeNewswire
Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer ... - Bluefield Daily Telegraph
Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface (“BCI”) Technology Private Subsidiary - TradingView
Helius Medical's New AI Brain Interface Venture Aims to Transform Neurorehabilitation Without Surgery - StockTitan
Helius Medical Technologies, Inc. Announces First Reimbursement by A Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device - The Manila Times
Helius Medical Technologies, Inc. Announces First - GlobeNewswire
Helius Medical announces first reimbursement for PoNS Device - TipRanks
Major Breakthrough: Anthem BCBS Approves $15,420 Payment for Helius Medical's PoNS Device - StockTitan
Helius Medical Technologies, Inc. (NASDAQ: HSDT) Featured in Coverage of the 37th Annual ROTH Conference - Financial Content
Helius Medical Tech Stock Price, Quotes and Forecasts | NASDAQ:HSDT - Benzinga
Helius Medical Technologies Moves Closer to Medicare Reimbursement, Expands Stroke Program - MSN
Analyzing Helius Medical Technologies (NASDAQ:HSDT) and Pheton Holdings Ltd Class A Ordinary Shares (NASDAQ:PTHL) - The AM Reporter
Neurology Devices Market Detailed In New Research Report 2025 | - openPR
Research Reports on BELLUS Health Helius Medical Technologies, Resverlogix, and Crescita Therapeutics - ACCESS Newswire
Helius Medical faces Nasdaq delisting over bid price By Investing.com - Investing.com Canada
Helius Medical Technologies (NASDAQ:HSDT) Shares Down 5.8% – What’s Next? - Armenian Reporter
1.09%
4.41%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):